Filter Results:
(1,143)
Show Results For
- All HBS Web
(1,143)
- People (1)
- News (316)
- Research (704)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
Show Results For
- All HBS Web
(1,143)
- People (1)
- News (316)
- Research (704)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
- 12 Jun 2018
- First Look
New Research and Ideas, June 12, 2018
forthcoming Cambridge, MA: Harvard University Press The Academy of Fisticuffs: Political Economy and Commercial Society in Enlightenment Italy By: Reinert, Sophus A. Abstract—The terms “capitalism” and... View Details
Keywords: Dina Gerdeman
- 10 Jul 2018
- First Look
New Research and Ideas, July 10, 2018
business plans, and key personnel ignited a bi-coastal battle between two fierce rivals that was played out in courts competing for jurisdiction and states with diametrically... View Details
Keywords: Dina Gerdeman
- 01 Jun 2018
- News
June 2018 Alumni and Faculty Books
a rising corporate attorney, was charged with murdering his lover, also a rising advertising executive in Manhattan. The dramatic trial that followed this incident played out for several years, mirroring the loss of sensibility to crime,... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
forthcoming World Happiness Report Happiness and Prosocial Behavior: An Evaluation of the Evidence By: Aknin, Lara B., A.V. Whillans, Michael I. Norton, and Elizabeth W. Dunn Abstract— Humans are an... View Details
Keywords: Dina Gerdeman
- Web
Speculation and Credit - Coin and Conscience – Baker Library | Bloomberg Center, Historical Collections
of Folly). It commemorates the period of speculative mania which swept France, England, and Holland in the year 1720. Pictured here is the inner court of the old Amsterdam exchange (see 66), where distraught... View Details
- 2023
- Working Paper
Market Exclusivity and Innovation: Evidence From Antibiotics
By: Edward Kong and Olivia Zhao
The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details
Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States
Kong, Edward, and Olivia Zhao. "Market Exclusivity and Innovation: Evidence From Antibiotics." Working Paper, December 2023.
- 14 May 2020
- News
Perspectives in Health: Everlywell, Diagnostics and COVID
- 2008
- Working Paper
Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya
By: Nava Ashraf, Xavier Gine and Dean Karlan
In much of the developing world, many farmers grow crops for local or personal consumption despite export options which appear to be more profitable. Thus many conjecture that one or several markets are missing. We report here on a randomized controlled trial conducted... View Details
Keywords: Agribusiness; Developing Countries and Economies; Trade; Profit; Product Marketing; Standards; Failure; Risk and Uncertainty; Non-Governmental Organizations; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Kenya; Europe
Ashraf, Nava, Xavier Gine, and Dean Karlan. "Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya." Harvard Business School Working Paper, No. 08-065, February 2008. (forthcoming, American Journal of Agricultural Economics.)
- 05 Feb 2019
- First Look
New Research and Ideas, February 5, 2019
US courts due to its status as a territory. In 2016, the US Congress had intervened, passing the Puerto Rico Oversight, Management, and Economic Stability Act (Promesa), which established an eight-member... View Details
Keywords: Dina Gerdeman
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
firms face little competition, even after the end of formal periods of patent protection and market exclusivity. Additionally, the evolving technologies of drug development—in particular, the increasingly common use of auxiliary endpoints... View Details
Keywords: Dina Gerdeman
- 13 Nov 2018
- First Look
New Research and Ideas, November 13, 2018
initiatives are fulfilling their desired objectives. By being able to more rigorously evaluate compliance programs with data and empirical analysis, prosecutors and courts will... View Details
Keywords: Dina Gerdeman
- 09 Apr 2019
- First Look
New Research and Ideas, April 9, 2019
After a first year of trial rollout in Israel, CEO Lihi Segal and her team are devising a global go-to-market plan for the firm. The team is considering several target markets, ranging from people with... View Details
Keywords: Dina Gerdeman
- 31 Aug 2021
- Book
Feeling Powerless at Work? Time to Agitate, Innovate, and Orchestrate
shantytowns. But in an effort to grow her organization and help more people, she eventually began courting private donors, public authorities, and the general public. By 2016,... View Details
Keywords: by Jay Fitzgerald
- 26 Jun 2014
- News
Investors Always Come Back … Even to Argentina
- January 2017
- Supplement
T. Rowe Price and the Dell Inc. MBO (B)
By: Lena G. Goldberg
After deciding to oppose the Dell MBO, T. Rowe Price, together with other dissident Dell shareholders, sought appraisal of their shares in the Delaware courts. The appraisal process resulted in a significant increase in the price to be paid to dissenting shareholders... View Details
Keywords: Fiduciary Duties; Management Buy-out; Ethics; Valuation; Courts and Trials; Business and Shareholder Relations; Restructuring; Financial Services Industry; Computer Industry; Delaware
Goldberg, Lena G. "T. Rowe Price and the Dell Inc. MBO (B)." Harvard Business School Supplement 317-089, January 2017.
- 30 Apr 2019
- First Look
New Research and Ideas, April 30, 2019
Sabine Oil & Gas Corporation In 2016, a trial began to determine the future of Sabine Oil & Gas Corporation’s $3 billion chapter 11 reorganization plan. The plan called for first- and... View Details
Keywords: Dina Gerdeman
- 22 Feb 2022
- News
March 2022 Alumni and Faculty Books
bloc or the programs that Soviets, East Germans, Cubans, Chinese, and other outsiders tried to promote. Instead, they attempted to forge new models of socialist development through their own trial View Details
- September 2017
- Case
Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry
By: Steven Rogers and Alyssa Haywoode
Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine... View Details
Keywords: Dr. Williams Carson; Otsuka America Pharmaceutical; Harvard; Abilify; Aripiprazole; Health Testing and Trials; Globalized Firms and Management; Globalized Markets and Industries; Cross-Cultural and Cross-Border Issues; Decision Choices and Conditions; Pharmaceutical Industry; Japan
Rogers, Steven, and Alyssa Haywoode. "Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry." Harvard Business School Case 318-005, September 2017.
- December 2004 (Revised August 2007)
- Background Note
LTCM's Profit Motive
By: Henry B. Reiling and Kevin Wall
This case summarizes the finding and reasoning inherent in the economic substance and penalty imposition holdings of the district court decision in Long Term Capital Holdings v. United States. The court upheld the IRS's contention that a transaction between Long Term... View Details
Reiling, Henry B., and Kevin Wall. "LTCM's Profit Motive." Harvard Business School Background Note 205-054, December 2004. (Revised August 2007.)
- March 2012 (Revised October 2013)
- Supplement
Gene Patents (B)
By: Richard Hamermesh and Phillip Andrews
The case updates events since the Court's ruling against Myriad Genetics on March 29, 2010 and should be used in conjunction with Gene Patents (A). On July 29, 2011, a US Appeals Court reversed the prior ruling against Myriad. On September 16, 2011, the first major... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Investment; Biotechnology Industry; United States
Hamermesh, Richard, and Phillip Andrews. "Gene Patents (B)." Harvard Business School Supplement 812-130, March 2012. (Revised October 2013.)